CBD Life Sciences Inc. CBDL
OTC PK
| 03/31/2024 | 03/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 42.90K | 31.50K | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 42.90K | 31.50K | |||
| Cost of Revenue | 25.10K | 14.50K | |||
| Gross Profit | 17.70K | 17.00K | |||
| SG&A Expenses | 70.10K | 40.60K | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 95.20K | 55.10K | |||
| Operating Income | -52.40K | -23.50K | |||
| Income Before Tax | -52.40K | -23.50K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -52.40K | -23.50K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.40K | -23.50K | |||
| EBIT | -52.40K | -23.50K | |||
| EBITDA | -33.90K | -5.00K | |||
| EPS Basic | 0.00 | 0.00 | |||
| Normalized Basic EPS | 0.00 | 0.00 | |||
| EPS Diluted | 0.00 | 0.00 | |||
| Normalized Diluted EPS | 0.00 | 0.00 | |||
| Average Basic Shares Outstanding | 135.69M | 135.69M | |||
| Average Diluted Shares Outstanding | 135.69M | 135.69M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||